Creatinine reduction ratio and 24-hour creatinine excretion on posttransplant day two: Simple and objective tools to define graft function

被引:49
作者
Govani, HV
Kwon, O
Batiuk, TD
Milgrom, ML
Filo, RS
机构
[1] Indiana Univ, Med Ctr, Div Nephrol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Med Ctr, Dept Surg, Indianapolis, IN 46202 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷 / 06期
关键词
D O I
10.1097/01.ASN.0000014253.40506.F6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To devise objective criteria for early diagnosis of delayed graft function (DGF), 59 adult living donor kidney transplants with immediate graft function (IGF) and 51 cadaveric kidney transplants were investigated for creatinine reduction ratio (CRR2) from posttransplant day 1 to day 2 and 24-h urine creatinine excretion (UC2) on day 2. The mean CRR2 in living donor transplants was 53% (SD +/- 11): the distribution of CRR2 was gaussian. and all of them had UC2 >1000 mg. Criteria for DGF were developed on the basis of living donor transplant: CRR2 less than or equal to 30% (2SD below 53%) +/- UC2 less than or equal to 1000 mg. Overall. 24 cadaver transplant recipients (47%) developed DGF (CRR2 less than or equal to 30%); 13 patients (25%) had mild DGF (UC2 >1000 mg), and the remaining 11 (22%) had severe DGF (UC2 less than or equal to 1000 mg). All the patients with severe DGF had a measured creatinine clearance <25 ml/min on day 7, and 8 of 11 were dialyzed within the first week of transplantation. Patients with IGF and mild DGF had a creatinine clearance of >= 25 ml/min on or before day 7. and none of them were dialyzed. Calcineurin inhibitors were avoided or delayed in five patients with mild DGF and all patients with severe DGF. In conclusion. diagnosing DGF within 48-h after transplantation is simple and may be valuable in the management of these patients.
引用
收藏
页码:1645 / 1649
页数:5
相关论文
共 14 条
  • [1] ALMOND PS, 1991, TRANSPLANT P, V23, P1304
  • [2] IMPROVED RESULTS USING OKT3 AS INDUCTION IMMUNOSUPPRESSION IN RENAL-ALLOGRAFT RECIPIENTS WITH DELAYED GRAFT FUNCTION
    BENVENISTY, AI
    COHEN, D
    STEGALL, MD
    HARDY, MA
    [J]. TRANSPLANTATION, 1990, 49 (02) : 321 - 327
  • [3] THE EFFECTS OF DELAYED FUNCTION ON RECIPIENTS OF CADAVER RENAL-ALLOGRAFTS - A STUDY OF 158 PATIENTS RANDOMIZED TO CYCLOSPORINE OR ALG-AZATHIOPRINE
    CANAFAX, DM
    TORRES, A
    FRYD, DS
    HEIL, JE
    STRAND, MH
    ASCHER, NL
    PAYNE, WD
    SUTHERLAND, DER
    SIMMONS, RL
    NAJARIAN, JS
    [J]. TRANSPLANTATION, 1986, 41 (02) : 177 - 181
  • [4] CARPENTER BJ, 1985, TRANSPLANT P, V17, P1282
  • [5] A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function
    Chang, GJ
    Mahanty, HD
    Vincenti, F
    Freise, CE
    Roberts, JP
    Ascher, NL
    Stock, PG
    Hirose, R
    [J]. CLINICAL TRANSPLANTATION, 2000, 14 (06) : 550 - 554
  • [6] Feldman HI, 1996, NEPHROL DIAL TRANSPL, V11, P1306
  • [7] Sirolimus (rapamycin)-based therapy in human renal transplantation -: Similar efficacy and different toxicity compared with cyclosporine
    Groth, CG
    Bäckman, L
    Morales, JM
    Calne, R
    Kreis, H
    Lang, P
    Touraine, JL
    Claesson, K
    Campistol, JM
    Durand, D
    Wramner, L
    Brattström, C
    Charpentier, B
    [J]. TRANSPLANTATION, 1999, 67 (07) : 1036 - 1042
  • [8] Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
    Kreis, H
    Cisterne, JM
    Land, W
    Wramner, L
    Squifflet, JP
    Abramowicz, D
    Campistol, JM
    Morales, JM
    Grinyo, JM
    Mourad, G
    Berthoux, FC
    Brattström, C
    Lebranchu, Y
    Vialtel, P
    [J]. TRANSPLANTATION, 2000, 69 (07) : 1252 - 1260
  • [9] Delayed graft function does not reduce the survival of renal transplant allografts
    Marcén, R
    Orofino, L
    Pascual, J
    de la Cal, MA
    Teruel, JL
    Villafruela, JJ
    Rivera, ME
    Mampaso, F
    Burgos, FJ
    Ortuño, J
    [J]. TRANSPLANTATION, 1998, 66 (04) : 461 - 466
  • [10] Delayed graft function: Risk factors and implications for renal allograft survival
    Ojo, AO
    Wolfe, RA
    Held, PJ
    Port, FK
    Schmouder, RL
    [J]. TRANSPLANTATION, 1997, 63 (07) : 968 - 974